Free Trial

Ekso Bionics Q3 2024 Earnings Report

Ekso Bionics logo
$0.58 -0.07 (-10.20%)
(As of 12/20/2024 05:31 PM ET)

Ekso Bionics EPS Results

Actual EPS
-$0.10
Consensus EPS
-$0.08
Beat/Miss
Missed by -$0.02
One Year Ago EPS
-$0.24

Ekso Bionics Revenue Results

Actual Revenue
$4.13 million
Expected Revenue
$6.00 million
Beat/Miss
Missed by -$1.87 million
YoY Revenue Growth
N/A

Ekso Bionics Announcement Details

Quarter
Q3 2024
Time
After Market Closes
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.

Ekso Bionics Earnings Headlines

Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Ekso Bionics to showcase device technology in ‘AI for Good’ Webinar
Ekso Gains, While Gearing up for “AI for Good”
See More Ekso Bionics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ekso Bionics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ekso Bionics and other key companies, straight to your email.

About Ekso Bionics

Ekso Bionics (NASDAQ:EKSO) designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

View Ekso Bionics Profile

More Earnings Resources from MarketBeat

Upcoming Earnings